argenx SE
ARGX
$649.67
$9.771.53%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/3/2025
-
Tickeron - Stocks
5/3/2025
-
MarketBeat
5/2/2025
-
Tickeron - Technical Analysis
5/2/2025
-
MarketBeat
5/1/2025
-
MarketBeat
5/1/2025
-
Tickeron - Technical Analysis
5/1/2025
-
Insider Monkey
5/1/2025
-
Globe Newswire
4/29/2025
-
Insider Monkey
4/29/2025
-
MarketBeat
4/29/2025
-
MarketBeat
4/28/2025
-
MarketBeat
4/28/2025
-
MarketBeat
4/28/2025
-
Globe Newswire
4/27/2025
-
Ticker Report
4/27/2025
-
MarketBeat
4/27/2025
-
Ticker Report
4/26/2025
-
MarketBeat
4/26/2025
-
Tickeron - Stocks
4/25/2025
-
ETF Channel
4/25/2025
-
MarketBeat
4/25/2025
-
MarketBeat
4/23/2025
-
Ticker Report
4/23/2025
-
MarketBeat
4/23/2025
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, March 20, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
31 10 703 8441
Address
Laarderhoogtweg 25
Amsterdam, 1101 EB
Amsterdam, 1101 EB
Country
Year Founded
Business Description
Sector
argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The...
more